---
$id: https://graph.org.ai/products/commodity/51182107
$type: Product
source: UNSPSC
code: "51182107"
title: "Conivaptan hydrochloride"
class: "51182100"
classTitle: "Posterior pituitary hormones"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Conivaptan hydrochloride

**UNSPSC Code**: 51182107
**Class**: [Posterior pituitary hormones](Posterior pituitary hormones.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vasopressin antagonist with the molecular formula C32H26N4O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75L57R6X36, chemically known as (1,1-biphenyl)-2-carboxamide, n-(4-(4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)- but more generally known as conivaptan hydrochloride, which bears US NIH Compound Identifier 151171. Most nations, for tariff and trade purposes, schedule conivaptan hydrochloride under HS 29339930 and SITC 51577. As of Q4 2014, CONIVAPTAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Conivaptan hydrochloride bears US NLM identifiers UMLS ID C1700196 and NCI Concept Code C65351. SMILES: CC1[NH]C-2C(N1)CCN(C3C2CCCC3)C(=O)C4CCC(CC4)NC(=O)C5CCCCC5C6CCCCC6.CL.

